In This Article:
The market has stayed flat over the past 7 days but has risen 34% in the past 12 months, with earnings forecast to grow by 15% annually. In this dynamic environment, identifying stocks with strong growth potential and solid fundamentals can uncover some of the most promising opportunities for investors.
Top 10 Undiscovered Gems With Strong Fundamentals In The United States
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Morris State Bancshares | 10.20% | -0.28% | 6.97% | ★★★★★★ |
Teekay | NA | -6.48% | 55.79% | ★★★★★★ |
Mission Bancorp | 25.37% | 16.23% | 20.16% | ★★★★★★ |
Omega Flex | NA | 1.31% | 3.88% | ★★★★★★ |
First Northern Community Bancorp | NA | 7.12% | 10.04% | ★★★★★★ |
Banco Latinoamericano de Comercio Exterior S. A | 311.64% | 21.07% | 24.77% | ★★★★★☆ |
United Bancorporation of Alabama | 13.34% | 18.86% | 25.45% | ★★★★★☆ |
San Juan Basin Royalty Trust | NA | 33.61% | 35.00% | ★★★★★☆ |
Valhi | 38.71% | 2.57% | -19.76% | ★★★★★☆ |
FRMO | 0.17% | 12.99% | 23.62% | ★★★★☆☆ |
Let's dive into some prime choices out of from the screener.
SBC Medical Group Holdings
Simply Wall St Value Rating: ★★★★★☆
Overview: SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, and internationally and has a market cap of $802.92 million.
Operations: SBC Medical Group Holdings generates revenue primarily from healthcare facilities and services, amounting to $217.54 million. The company has a market cap of $802.92 million.
SBC Medical Group Holdings, a small-cap healthcare player, has seen impressive earnings growth of 164% over the past year, outpacing the industry average of 8%. Despite its high volatility in share price recently and substantial shareholder dilution, SBC remains profitable with levered free cash flow reaching US$64.23 million by mid-2024. Trading at 92.9% below its estimated fair value and added to the NASDAQ Composite Index in September 2024, it presents an intriguing investment case.
Centrus Energy
Simply Wall St Value Rating: ★★★★★☆
Overview: Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally with a market cap of $892.95 million.
Operations: Centrus Energy generates revenue primarily through its Low-Enriched Uranium (LEU) segment, which contributed $320.80 million, and its Technical Solutions segment, adding $71.80 million. The company has a market cap of $892.95 million and reported a Segment Adjustment of -$5 million.